|
Retinal stimulator
Link to Contact Information (Only For Members of GetOwner Role)
Ref: TO
2578
Submission Date:
03/09/2019
Active before:
31/12/2021
Contact Information
Department:
The Department of Physics, Mathematics and Informatics
Organization:
The State Scientific Institution "The B.I. Stepanov Institute of Physics of the National Academy of Sciences of Belarus"
Name:
Jarnikova Ekaterina
Email:
ifanbel@ifanbel.bas-net.by
Telephone:
+375172841750
Link to website:
[url]http://ifanbel.bas-net.by/[/url]
Link to the corresponding profile in Russian
| |
|
Description
The tricolor retinal stimulator is intended for the treatment of ophthalmologic diseases and removal of eye fatigue. The retinal stimulator is used for treatment by affecting the retina of the eye with the combined radiation of three wavelengths located at the maxima of the spectral sensitivity of the eye. There are two modifications of the device: laser and LED.[br][/br]Specifications:[br][/br][br][/br]Working wavelengths: 0.43 microns; 0.53 microns; 0.57 microns[br][/br]The power of the light pulse at the output of the optical head: 0.08 — 2 mW[br][/br]Automatic dosing time of exposure: 1 — 30 min (in 1 min increments)[br][/br]Duration of a light impulse: 0,01 — 1 with[br][/br]Pulse repetition rate: 1 — 100 Hz (in 1 Hz steps)[br][/br]Installation time: 30 minutes[br][/br]Power supply: 220 V, 50 Hz[br][/br]Cooling: natural[br][/br]Power supply dimensions: 210 x 160 x 125 mm[br][/br]Optical head dimensions: 138 x 135 mm[br][/br]Power unit weight: 1.7 kg[br][/br]Optical head weight: 0.18 kg
Technology Type
Design
Technology Benefits
Advantages: the retinal stimulator is more effective compared to the traditionally used devices based on helium-neon lasers. So, with the use of a three-color retinal stimulator, an increase in visual acuity was observed in 75% of cases, whereas when exposed to radiation from a helium-neon laser, this figure was 47%.
Technology Differentiation and Uniqueness
new design
Technological Keywords
Tricolor, retinal stimulator, treatment of ophthalmologic diseases, eye fatigue.
Development Stage
Prototype (demonstration available for testing)
Results of demonstration test available
Currently in use/production
Intellectual Property Rights
Secret Know-How
Range of Applications
medicine
Classifier Used at the Enterprise Europe Network
Biotech, Pharma and Cosmetics
Healthcare
Preferable Regions
North America
South America
Europe
Asia
Africa
Australia
Environmental Impact
no
Type of Collaboration Sought
R&D Contract
License
For Sale
Terms&Restrictions
no
Available Technical Assistance
Documentation
Personnel
|
